[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Exelixis Inc (EXEL)
Exelixis Inc (EXEL) stock is down despite positive trial results. Investors are likely taking profits, according to recent social media activity.
About Exelixis Inc
Exelixis Inc (EXEL) is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for difficult-to-treat cancers.
Exelixis Inc uses the ticker $EXEL for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Exelixis Inc (EXEL) trading volume is up XXXXX% from the previous year.
- Exelixis Inc (EXEL) galaxy score™ is up XXXXX% from the previous week.
- Exelixis Inc (EXEL) sentiment is up XXXXX% from the previous week.
- Exelixis Inc (EXEL) mentions is up XXXXXX% from the previous month.
- Exelixis Inc (EXEL) posts created is up XXXXX% from the previous month.
Price: $XXXXX #
Price 24-Hour Chart Data
The stock price is down despite positive trial results. Portfolio adjustments and profit-taking, as suggested by mentions in stock lists and investor behavior, are likely the primary drivers of the price decrease, despite positive trial results.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| XXXX% | -XXXX% | -XXXX% |
1-Year High: $XXXXX on 2025-05-15
1-Year Low: $XXXXX on 2024-07-24
AltRank: XXXXX #
AltRank 24-Hour Chart Data
Exelixis Inc (EXEL) is currently AltRank #1,196 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +530
1 Month: XXXXX -XXX
6 Months: XXXXX +525
1 Year: XXXXX +308
1-Year High: XXXXX on 2025-05-06
1-Year Low: XX on 2025-05-15
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +18
1 Month: XX +8
6 Months: XX +15
1 Year: XX +12
1-Year High: XX on 2024-08-06
1-Year Low: X on 2024-12-09
Engagements: XXXXX #
Engagements 24-Hour Chart Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +395%
1 Year: XXXXXXXXX +344%
1-Year High: XXXXXXX on 2025-05-28
1-Year Low: XX on 2025-07-23
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XXX #
Mentions 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Week: XXX +11%
1 Month: XXXXX +337%
6 Months: XXXXX +63%
1 Year: XXXXX +321%
1-Year High: XXX on 2025-06-24
1-Year Low: X on 2024-07-31
| Social Network | X | YouTube |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Chart Data
XX unique social accounts have posts mentioning Exelixis Inc (EXEL) in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Week: XXX +9.40%
1 Month: XXXXX +447%
6 Months: XXXXX +90%
1 Year: XXXXX +425%
1-Year High: XXX on 2025-06-24
1-Year Low: X on 2024-07-31
The most influential creators that mention Exelixis Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Tickeron | X | XXXXXX | X | XXX |
| @SteveDJacobs | X | XXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% +19%
1 Month: XX% -XX%
6 Months: XX% +25%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-07-24
1-Year Low: XX% on 2025-02-10
Most Supportive Themes
- Positive Trial Results: (25%) Exelixis's kidney cancer treatment shows promising results.
- Growth Stock Recognition: (20%) Exelixis was recognized as an Affordable Growth stock.
- Conference Presentations: (15%) Exelixis's participation in investor conferences increased visibility and engagement.
Most Critical Themes
- Negative News Reiteration: (4%) Negative news and outlooks regarding Exelixis Inc.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| YouTube | X | X% | X | X% | X | X% |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXX% -XXXXXXX%
1 Month: XXXXX% -XXXXX%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-06-24
1-Year Low: XXXXXX% on 2024-07-31
Market Dominance: XXXXX% #
Market Dominance 24-Hour Chart Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-03-31
1-Year Low: XXXX% on 2024-07-24
Market Cap: $XXXXXXXXXXXXXX #
Market Cap 24-Hour Chart Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$0.75%
1 Month: $XXXXXXXXXXXXXX +$10%
6 Months: $XXXXXXXXXXXXXX +$24%
1 Year: $XXXXXXXXXXXXXX +$84%
1-Year High: $XXXXXXXXXXXXXX on 2025-05-15
1-Year Low: $XXXXXXXXXXXXX on 2024-07-24
Top assets mentioned In the posts about Exelixis Inc in the last XX hours
Sarepta Therapeutics, Inc. (SRPT) Regeneron Pharmaceuticals Inc (REGN) ZetaChain (ZETA) Vertex Protocol (VRTX) Neurocrine Biosciences, Inc. (NBIX) Newmont Corporation (NEM) SuperRare (RARE) Bitcoin Incognito (XBI) Argo Blockchain plc (ARBK)
Top topics mentioned In the posts about Exelixis Inc in the last XX hours
$srpt, $adpt, $bcrx, $nktr, mrna, $regn, nvda, pltr, sei, baba, stocks, telo, dtc, $qntm, op, smci, nxt, nem, $tigr, meta, investment, oscr, $zeta, jbl, rklb, stocks healthcare, manat, $arm, $cmcl, $sieb, eps, $vrtx, $ctmx, avgo, flr, $legn, $nbix, hims, wmt, msft, hood, $nem, $rare, amzn, prim, abc, nasdaq, iren, $xbi, neural, sonn, $glyc, $gamb, $bsem, $arbk, jpm, $sn, mstr, $uthr, $deck, deckers outdoor corp, ibkr, goog, ebay, flo, $mmp, $chgg, $ew, edwards lifesciences corp, bap, arlo, $foxa, $avxl, $grfs, $dvn, hum, $wksp, $arna, $xpev, $amd, iag, qbts, aap, sats, neu, $hik, $dyn, moh, cah, ip, coins ai, $6758t, sony, $chef, $reymi, cvx, $geat, slack, zoom, $tsm
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@mikealfred $EXEL is still my fav midcap biotech despite the run its had. Still has a double in it"
@perry_lin1 on X 2025-07-22 22:49:20 UTC 1239 followers, XXX engagements
"$DVN -Raymond James raises Devon Energy target to $XX from $XX Outperform - $EA -Wedbush reissues Electronic Arts $XXX target Outperform - $ELV -JPMorgan lowers Elevance Health target to $XX from $XXX Overweight - $EXEL -Morgan Stanley raises Exelixis target to $XX from $XX Overweight -"
@MarcJacksonLA on X 2025-07-22 22:30:26 UTC 7093 followers, XXX engagements
"$STOK Stock Stoke Therapeutics (STOK $13.22) was a top quarterly gainer rising +71.91% $REGN $INCY $EXEL $MRNA $ARWR $BCRX $ADPT $SRPT $NVAX $NKTR"
@Tickeron on X 2025-07-22 20:40:21 UTC 19K followers, XXX engagements
"$PALI Penny Stock The volume for Palisade Bio stock increased for one day resulting in a record-breaking daily growth of XXX% of the 65-Day Volume Moving Average $REGN $INCY $EXEL $MRNA $ARWR $BCRX $ADPT $SRPT $NVAX $NKTR"
@Tickeron on X 2025-07-22 20:34:49 UTC 19K followers, XXX engagements